Quarterly Results • Search Archive
Accent Microcell Limited
Results, Financials & Updates
Follow Accent Microcell Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
1 published deep dive
1 quarter 1 sector
Company Overview
Accent Microcell Limited: latest results and financials
About the business in Nivata's latest coverage
Accent Microcell Limited manufactures pharmaceutical excipients, primarily specializing in Microcrystalline Cellulose (MCC), Croscarmellose Sodium (CCS), Sodium Starch Glycolate (SSG), and Carboxymethylcellulose (CMC). These excipients are essential binding, disintegrating, and filling agents widely utilized by pharmaceutical, nutraceutical, and food companies in tablet and capsule formulations. The company operates three manufacturing facilities located in Gujarat: the Dahej SEZ unit, the Pirana plant, and the Unit III facility at Nayka. The Dahej SEZ unit serves as a major export engine, contributing significantly to overseas sales, whereas the Pirana plant caters extensively to domestic demand.
Quarter history
Accent Microcell Limited Results & Financials
Latest Nivata coverage: Q2 FY27 · revenue ₹174.83 Cr · PAT ₹31.12 Cr.
Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.